Molecular consequences of dominant Bethlem myopathy collagen VI mutations
(2007) In Annals of Neurology 62(4). p.390-405- Abstract
- Objective: Dominant mutations in the three collagen VI genes cause Bethlem myopathy, a disorder characterized by proximal muscle weakness and commonly contractures of the fingers, wrists, and ankles. Although more than 20 different dominant mutations have been identified in Bethlem myopathy patients, the biosynthetic consequences of only a subset of these have been studied, and in many cases, the pathogenic mechanisms remain unknown. Methods: We have screened fourteen Bethlem myopathy patients for collagen VI mutations and performed detailed analyses of collagen VI biosynthesis and intracellular and extracellular assembly. Results: Collagen VI abnormalities were identified in eight patients. One patient produced around half the normal... (More)
- Objective: Dominant mutations in the three collagen VI genes cause Bethlem myopathy, a disorder characterized by proximal muscle weakness and commonly contractures of the fingers, wrists, and ankles. Although more than 20 different dominant mutations have been identified in Bethlem myopathy patients, the biosynthetic consequences of only a subset of these have been studied, and in many cases, the pathogenic mechanisms remain unknown. Methods: We have screened fourteen Bethlem myopathy patients for collagen VI mutations and performed detailed analyses of collagen VI biosynthesis and intracellular and extracellular assembly. Results: Collagen VI abnormalities were identified in eight patients. One patient produced around half the normal amount of alpha 1(VI) messenger RNA and reduced amounts of collagen VI protein. Two patients had a previously reported mutation causing skipping of COL6A1 exon 14, and three patients had novel mutations leading to in-frame deletions toward the N-terminal end of the triple-helical domain. These mutations have different and complex effects on collagen VI intracellular and extracellular assembly. Two patients had single amino acid substitutions in the A-domains of COL6A2 and COL6A3. Collagen VI intracellular and extracellular assembly was normal in one of these patients. Interpretation: The key to dissecting the pathogenic mechanisms of collagen VI mutations lies in detailed analysis of collagen VI biosynthesis and assembly. The majority of mutations result in secretion and deposition of structurally abnormal collagen VI. However, one A-domain mutation had no detectable effect on assembly, suggesting that it acts by compromising collagen VI interactions in the extracellular matrix of muscle. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/974442
- author
- organization
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Annals of Neurology
- volume
- 62
- issue
- 4
- pages
- 390 - 405
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- wos:000250689300011
- scopus:36148953276
- pmid:17886299
- ISSN
- 1531-8249
- DOI
- 10.1002/ana.21213
- language
- English
- LU publication?
- yes
- id
- b4e64e78-035a-4237-bde4-339243f06988 (old id 974442)
- date added to LUP
- 2016-04-01 11:39:51
- date last changed
- 2022-01-26 08:22:30
@article{b4e64e78-035a-4237-bde4-339243f06988,
abstract = {{Objective: Dominant mutations in the three collagen VI genes cause Bethlem myopathy, a disorder characterized by proximal muscle weakness and commonly contractures of the fingers, wrists, and ankles. Although more than 20 different dominant mutations have been identified in Bethlem myopathy patients, the biosynthetic consequences of only a subset of these have been studied, and in many cases, the pathogenic mechanisms remain unknown. Methods: We have screened fourteen Bethlem myopathy patients for collagen VI mutations and performed detailed analyses of collagen VI biosynthesis and intracellular and extracellular assembly. Results: Collagen VI abnormalities were identified in eight patients. One patient produced around half the normal amount of alpha 1(VI) messenger RNA and reduced amounts of collagen VI protein. Two patients had a previously reported mutation causing skipping of COL6A1 exon 14, and three patients had novel mutations leading to in-frame deletions toward the N-terminal end of the triple-helical domain. These mutations have different and complex effects on collagen VI intracellular and extracellular assembly. Two patients had single amino acid substitutions in the A-domains of COL6A2 and COL6A3. Collagen VI intracellular and extracellular assembly was normal in one of these patients. Interpretation: The key to dissecting the pathogenic mechanisms of collagen VI mutations lies in detailed analysis of collagen VI biosynthesis and assembly. The majority of mutations result in secretion and deposition of structurally abnormal collagen VI. However, one A-domain mutation had no detectable effect on assembly, suggesting that it acts by compromising collagen VI interactions in the extracellular matrix of muscle.}},
author = {{Baker, Naomi L. and Mörgelin, Matthias and Pace, Rishika A. and Peat, Rachel A. and Adams, Naomi E. and Gardner, R. J. McKinlay and Rowland, Lewis P. and Miller, Geoffrey and De Jonghe, Peter and Ceulemans, Berten and Hannibal, Mark C. and Edwards, Matthew and Thompson, Elizabeth M. and Jacobson, Richard and Quinlivan, Ros C. M. and Aftimos, Salim and Kornberg, Andrew J. and North, Kathryn N. and Bateman, John F. and Lamande, Shireen R.}},
issn = {{1531-8249}},
language = {{eng}},
number = {{4}},
pages = {{390--405}},
publisher = {{John Wiley & Sons Inc.}},
series = {{Annals of Neurology}},
title = {{Molecular consequences of dominant Bethlem myopathy collagen VI mutations}},
url = {{http://dx.doi.org/10.1002/ana.21213}},
doi = {{10.1002/ana.21213}},
volume = {{62}},
year = {{2007}},
}